Marshall Wace North America’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Marshall Wace North America’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell
2018 Q2	$744K	Buy
2017 Q3	–	Sell
2017 Q2	$6.66M	Sell
2017 Q1	$9.36M	Buy